DIN 02498243 — SARCLISA 500 MG
SARCLISA is a solution of Isatuximab marketed by SANOFI-AVENTIS CANADA INC. The full Isatuximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02498243
- Brand name
- SARCLISA
- Active ingredient
- Isatuximab
- Strength
- 500 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-CD38 monoclonal antibody (antineoplastic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Isatuximab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02498235 | SARCLISA | 100 MG | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |